Literature DB >> 27073650

Diagnostic value of dynamic contrast-enhanced magnetic resonance imaging in rectal cancer and its correlation with tumor differentiation.

F U Shen1, Jianping Lu1, Luguang Chen1, Zhen Wang1, Yukun Chen1.   

Abstract

Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a novel imaging modality that can be used to reflect the microcirculation, although its value in diagnosing rectal cancer is unknown. The present study aimed to explore the clinical application of DCE-MRI in the preoperative diagnosis of rectal cancer, and its correlation with tumor differentiation. To achieve this, 40 pathologically confirmed patients with rectal cancer and 15 controls were scanned using DCE-MRI. The Tofts model was applied to obtain the perfusion parameters, including the plasma to extravascular volume transfer (Ktrans), the extravascular to plasma volume transfer (Kep), the extravascular fluid volume (Ve) and the initial area under the enhancement curve (iAUC). Receiver-operating characteristic (ROC) curves were plotted to determine the diagnostic value. The results demonstrated that the time-signal intensity curve of the rectal cancer lesion exhibited an outflow pattern. The Ktrans, Kep, Ve, and iAUC values were higher in the cancer patients compared with controls (P<0.05). The intraclass correlation coefficients of Ktrans, Kep, Ve and iAUC, as measured by two independent radiologists, were 0.991, 0.988, 0.972 and 0.984, respectively (all P<0.001), indicating a good consistency. The areas under the ROC curves for Ktrans and iAUC were both >0.9, resulting in a sensitivity and specificity of 100% and 93.3% for Ktrans, and of 92.5%, and 93.3% or 100%, for iAUC, respectively. In the 40 rectal cancer cases, there was a moderate correlation between Ktrans and iAUC, and pathological differentiation (0.3<r<0.8, all P<0.05). In conclusion, Ktrans and iAUC were associated with the presence of rectal cancer and differentiation, and therefore may provide novel insights into the preoperative diagnosis of rectal cancer.

Entities:  

Keywords:  diagnosis; differentiation; dynamic contrast-enhanced magnetic resonance imaging; rectal cancer; tumor differentiation

Year:  2016        PMID: 27073650      PMCID: PMC4812157          DOI: 10.3892/mco.2016.762

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  26 in total

1.  Assessment of dynamic contrast-enhanced magnetic resonance imaging in the differentiation of malignant from benign orbital masses.

Authors:  Ying Yuan; Xin-Ping Kuai; Xiao-Song Chen; Xiao-Feng Tao
Journal:  Eur J Radiol       Date:  2013-04-03       Impact factor: 3.528

2.  Positive enhancement integral values in dynamic contrast enhanced magnetic resonance imaging of breast carcinoma: ductal carcinoma in situ vs. invasive ductal carcinoma.

Authors:  Mirjan Nadrljanski; Ružica Maksimović; Vesna Plešinac-Karapandžić; Marina Nikitović; Biljana Marković-Vasiljković; Zorica Milošević
Journal:  Eur J Radiol       Date:  2014-05-16       Impact factor: 3.528

Review 3.  Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.

Authors:  Nola Hylton
Journal:  J Clin Oncol       Date:  2006-07-10       Impact factor: 44.544

Review 4.  Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.

Authors:  Rakesh K Jain
Journal:  Science       Date:  2005-01-07       Impact factor: 47.728

Review 5.  Colorectal cancer.

Authors:  David Cunningham; Wendy Atkin; Heinz-Josef Lenz; Henry T Lynch; Bruce Minsky; Bernard Nordlinger; Naureen Starling
Journal:  Lancet       Date:  2010-03-20       Impact factor: 79.321

6.  Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens.

Authors:  Philippe Puech; Eric Potiron; Laurent Lemaitre; Xavier Leroy; Georges-Pascal Haber; Sebastien Crouzet; Kazumi Kamoi; Arnauld Villers
Journal:  Urology       Date:  2009-09-20       Impact factor: 2.649

7.  Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma.

Authors:  Olwen M Hahn; Cheng Yang; Milica Medved; Gregory Karczmar; Emily Kistner; Theodore Karrison; Elizabeth Manchen; Myrosia Mitchell; Mark J Ratain; Walter M Stadler
Journal:  J Clin Oncol       Date:  2008-10-01       Impact factor: 44.544

Review 8.  Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Alan Jackson; James P B O'Connor; Geoff J M Parker; Gordon C Jayson
Journal:  Clin Cancer Res       Date:  2007-06-15       Impact factor: 12.531

Review 9.  Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

Authors:  P S Tofts; G Brix; D L Buckley; J L Evelhoch; E Henderson; M V Knopp; H B Larsson; T Y Lee; N A Mayr; G J Parker; R E Port; J Taylor; R M Weisskoff
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813

10.  Correlations of dynamic contrast-enhanced magnetic resonance imaging with morphologic, angiogenic, and molecular prognostic factors in rectal cancer.

Authors:  Hye-Suk Hong; Se Hoon Kim; Hae-Jeong Park; Mi-Suk Park; Ki Whang Kim; Won Ho Kim; Nam Kyu Kim; Jae Mun Lee; Hyeon Je Cho
Journal:  Yonsei Med J       Date:  2013-01-01       Impact factor: 2.759

View more
  8 in total

Review 1.  Dynamic contrast-enhanced (DCE) imaging: state of the art and applications in whole-body imaging.

Authors:  Domenico Albano; Federico Bruno; Andrea Agostini; Salvatore Alessio Angileri; Massimo Benenati; Giulia Bicchierai; Michaela Cellina; Vito Chianca; Diletta Cozzi; Ginevra Danti; Federica De Muzio; Letizia Di Meglio; Francesco Gentili; Giuliana Giacobbe; Giulia Grazzini; Irene Grazzini; Pasquale Guerriero; Carmelo Messina; Giuseppe Micci; Pierpaolo Palumbo; Maria Paola Rocco; Roberto Grassi; Vittorio Miele; Antonio Barile
Journal:  Jpn J Radiol       Date:  2021-12-24       Impact factor: 2.374

2.  Role of dynamic perfusion magnetic resonance imaging in patients with local advanced rectal cancer.

Authors:  Davide Ippolito; Silvia Girolama Drago; Anna Pecorelli; Cesare Maino; Giulia Querques; Ilaria Mariani; Cammillo Talei Franzesi; Sandro Sironi
Journal:  World J Gastroenterol       Date:  2020-05-28       Impact factor: 5.742

Review 3.  Colorectal cancer: Parametric evaluation of morphological, functional and molecular tomographic imaging.

Authors:  Pier Paolo Mainenti; Arnaldo Stanzione; Salvatore Guarino; Valeria Romeo; Lorenzo Ugga; Federica Romano; Giovanni Storto; Simone Maurea; Arturo Brunetti
Journal:  World J Gastroenterol       Date:  2019-09-21       Impact factor: 5.742

4.  Comparison of Intravoxel incoherent motion imaging and multiecho dynamic contrast-based MRI in rectal cancer.

Authors:  Kine Mari Bakke; Endre Grøvik; Sebastian Meltzer; Anne Negård; Stein Harald Holmedal; Lars Tore G Mikalsen; Lars Gustav Lyckander; Anne H Ree; Kjell-Inge Gjesdal; Kathrine R Redalen; Atle Bjørnerud
Journal:  J Magn Reson Imaging       Date:  2019-04-04       Impact factor: 4.813

5.  Preoperative Prediction of Extramural Venous Invasion in Rectal Cancer: Comparison of the Diagnostic Efficacy of Radiomics Models and Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging.

Authors:  Xiangling Yu; Wenlong Song; Dajing Guo; Huan Liu; Haiping Zhang; Xiaojing He; Junjie Song; Jun Zhou; Xinjie Liu
Journal:  Front Oncol       Date:  2020-04-09       Impact factor: 6.244

6.  Follow-Up of High-Grade Glial Tumor; Differentiation of Posttreatment Enhancement and Tumoral Enhancement by DCE-MR Perfusion.

Authors:  Tolga Turan Dündar; Ezra Cetinkaya; İsmail Yurtsever; Ömer Uysal; Ayşe Aralaşmak
Journal:  Contrast Media Mol Imaging       Date:  2022-02-01       Impact factor: 3.161

7.  DCE-MRI radiomics models predicting the expression of radioresistant-related factors of LRP-1 and survivin in locally advanced rectal cancer.

Authors:  Zhiheng Li; Huizhen Huang; Chuchu Wang; Zhenhua Zhao; Weili Ma; Dandan Wang; Haijia Mao; Fang Liu; Ye Yang; Weihuo Pan; Zengxin Lu
Journal:  Front Oncol       Date:  2022-08-29       Impact factor: 5.738

8.  Assessing Microcirculation in Resectable Oesophageal Squamous Cell Carcinoma with Dynamic Contrast-enhanced MRI for Identifying Primary tumour and Lymphatic Metastasis.

Authors:  Yan-Li Chen; Yu Jiang; Tian-Wu Chen; Rui Li; Xiao-Ming Zhang; Fan Chen; Lan Wu; Jing Ou; Jian-Qiong Yang
Journal:  Sci Rep       Date:  2019-01-15       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.